Spectacle Lenses With Highly Aspherical Lenslets for Myopia Control: A Randomized Clinical Trial

Lenses

Defocus Incorporated Multiple Segments (DIMS) Spectacle Lenses Versus Single-Vision Lenses for Pediatric Myopia: A Systematic Review and Meta-Analysis

Am J Ophthalmol

Al-Shammari YM, Alkandari SA, Al-Shammari RM, Al-Mahdi Al-Kurdi M, Aljassar F

doi: 10.1016/j.ajo.2026.02.045

Lenses

The Influence of Highly Aspherical Lenslets on Choroidal Thickness and Axial Length

J Clin Med

Paulasto L, Carré C, Loertscher M

doi: 10.3390/jcm14197059

Further Publications

Time-Varying Effects of Valacyclovir Prophylaxis in the Zoster Eye Disease Study: A Post Hoc Exploratory Analysis of a Randomized Clinical Trial

JAMA Ophthalmol

Warner DB, Lee TF, Troxel AB, Prescott C, Cohen EJ, Jeng BH, ZEDS Trial Research Group

doi: 10.1001/jamaophthalmol.2026.3202

Further Publications

Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction: Follow-Up of a Randomized Clinical Trial

JAMA Ophthalmol

Prajna NV, Bernard A, Prajna L, Rajaraman R, Sharma SS, Christy J, Radhakrishnan N, Mandlik K, De Freitas D, Höfling-Lima AL, Varnado NE, Abdelrahman S, Arnold BF, Lietman TM, Rose-Nussbaumer J, REAGIR Research Group

doi: 10.1001/jamaophthalmol.2026.2257

Retinal Diseases

Brolucizumab in the Treatment of Proliferative Diabetic Retinopathy: The CONDOR Randomized Clinical Trial

JAMA Ophthalmol

Wolf S, Chen Y, Li X, Shimura M, Sakamoto T, Wykoff CC, Emanuelli A, Salehi-Had H, Yan K, Kovacic L, Kim Y

doi: 10.1001/jamaophthalmol.2026.1008

Further Publications

Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial

JAMA Ophthalmol

Lee WK, Wong TY, Chen SJ, Sun X, Cheung CMG, Silva R, Ricci F, Zhang X, Machewitz T, Schulze A, Schmidt-Ott UM, Zhao M, Hasanbasic Z, Leal S, Iida T, PULSAR Study Investigators

doi: 10.1001/jamaophthalmol.2025.5098

Retinal DiseasesFurther Publications

Safety and Effects of Gildeuretinol Acetate on Retinal Atrophic Lesions in Stargardt Disease: The TEASE-1 Randomized Clinical Trial

JAMA Ophthalmol

Kay CN, Saad L, DeBartolomeo G, Bressler N, Tsang SH, Stepien K, Bernstein P, Lam BL, Washington I, Gorin MB, TEASE-1 Study Group

doi: 10.1001/jamaophthalmol.2026.3662

Uveitis

Dazdotuftide: Novel Treatment for Non-Infectious Uveitis with Superior Intraocular Pressure Safety Profile: A Randomized Clinical Trial

Am J Ophthalmol

Chu DS, Tsui E, Rifkin LM, Palestine AG, Rich C, Thorne JE, Haim-Langford D, Milman Z, Fulcher E, Neumann R, de Smet MD, TRS4Vision Study Group

doi: 10.1016/j.ajo.2025.12.034

Further Publications

Donor Diabetes and 1-Year Descemet Membrane Endothelial Keratoplasty Success Rate: A Randomized Clinical Trial

JAMA Ophthalmol

Price FW Jr, Szczotka-Flynn LB, Price MO, Bauza CE, Reed ZW, Arafah BM, Greiner MA, Johnson PJ, Keeler DB, Mian SI, Patel SV, Pramanik S, Soper MC, Terry MA, Titus MS, Verdier DD, Kollman C, Beck RW, Lass JH, Diabetes Endothelial Keratoplasty Study Group

doi: 10.1001/jamaophthalmol.2025.4253

Related content

Defocus Incorporated Multiple Segments (DIMS) Spectacle Lenses Versus Single-Vision Lenses for Pediatric Myopia: A Systematic Review and Meta-Analysis

The Influence of Highly Aspherical Lenslets on Choroidal Thickness and Axial Length

Time-Varying Effects of Valacyclovir Prophylaxis in the Zoster Eye Disease Study: A Post Hoc Exploratory Analysis of a Randomized Clinical Trial

Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction: Follow-Up of a Randomized Clinical Trial

Brolucizumab in the Treatment of Proliferative Diabetic Retinopathy: The CONDOR Randomized Clinical Trial

Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial

Safety and Effects of Gildeuretinol Acetate on Retinal Atrophic Lesions in Stargardt Disease: The TEASE-1 Randomized Clinical Trial

Dazdotuftide: Novel Treatment for Non-Infectious Uveitis with Superior Intraocular Pressure Safety Profile: A Randomized Clinical Trial

Donor Diabetes and 1-Year Descemet Membrane Endothelial Keratoplasty Success Rate: A Randomized Clinical Trial